Product Details for NDA 020822
CELEXA (CITALOPRAM HYDROBROMIDE)
EQ 10MG BASE
Marketing Status: Prescription
EQ 20MG BASE
Marketing Status: Prescription
EQ 40MG BASE
Marketing Status: Prescription
EQ 60MG BASE
Marketing Status: Discontinued
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020822
Product Number: 001
Approval Date: Apr 27, 2000
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Prescription
Patent and Exclusivity Information
CELEXA (CITALOPRAM HYDROBROMIDE)
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020822
Product Number: 001
Approval Date: Apr 27, 2000
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 20MG BASE
Marketing Status: Prescription
Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020822
Product Number: 002
Approval Date: Jul 17, 1998
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Prescription
Patent and Exclusivity Information
CELEXA (CITALOPRAM HYDROBROMIDE)
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020822
Product Number: 002
Approval Date: Jul 17, 1998
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 40MG BASE
Marketing Status: Prescription
Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020822
Product Number: 003
Approval Date: Jul 17, 1998
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Prescription
Patent and Exclusivity Information
CELEXA (CITALOPRAM HYDROBROMIDE)
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020822
Product Number: 003
Approval Date: Jul 17, 1998
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 60MG BASE
Marketing Status: Discontinued
Active Ingredient: CITALOPRAM HYDROBROMIDE
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020822
Product Number: 004
Approval Date: Jul 17, 1998
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: CELEXA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020822
Product Number: 004
Approval Date: Jul 17, 1998
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information